In the SOUL trial, published in March 2025 in the New England Journal of Medicine , researchers studied 9,650 participants aged 50 and older with type 2 diabetes and either cardiovascular or kidney disease
The antifibrinolytic agent tranexamic acid is a first-line non-hormonal therapy for heavy menstrual bleeding, but not without some risks, notably venous thromboembolism
6c), since we predicted that activation of the NRF2 pathway would protect cells against LCS3-mediated oxidative stress
These attacks disrupt our entire way of living. A 44-year-old resident of Kapedo who requested to go by the pseudonym Mary, out of fear of recrimination from local authorities, claims that she will never move from her hometown
Our team can help verify your insurance requirements
This action could lead to decreased food consumption and contribute to weight reduction [3]